Shijiazhuang Kaixai Pharmaceutical Technology Co., Ltd. has established a Shijiazhuang R&D platform and experimental base that complies with GMP requirements, as well as a Beijing registration and filing platform. The management team possesses overseas pharmaceutical technology CRO operational concepts and successful experience, and the core technical personnel come from well-known pharmaceutical companies at home and abroad. In accordance with ICH requirements, it provides the following services to domestic and foreign pharmaceutical companies:
New drug development and generic drug consistency evaluation;
API process development and related impurity studies;
API analytical method development and formulation prescription studies;
Excipient and packaging material compatibility studies;
Consistency evaluation for solid oral preparations, injections, and eye drops;
Domestic and foreign registration (FDA, EMEA, TGA, etc.) for pharmaceutical products such as APIs, formulations, excipients, packaging materials, etc.